ABSTRACT The intracellular movement of cell surface transferrin receptor (TfR) after internalization was studied in K562 cultured human erythroleukemia cells. The sialic acid residues of the TfR glycoprotein were used to monitor transport to the Golgi complex, the site of sialyltransferases. Surface-labeled cells were treated with neuraminidase, and readdition of sialic acid residues, monitored by isoelectric focusing of immunoprecipitated TfR, was used to assess the movement of receptor to sialyltransferase-containing compartments. Asialo-TfR was resialylated by the cells with a half-time of 2-3 h. Resialylation occurred in an intracellular organelle, since it was inhibited by treatments that allow internalization of surface components but block transfer out of the endosomal compartment. Moreover, roughly half of the resialylated molecules were cleaved when cells were retreated with neuraminidase after culturing, indicating that this fraction of the molecules had returned to the cell surface. These results suggest that TfR is transported from the cell surface to the Golgi complex, the intracellular site of sialyltransferases, and then returns to the cell surface. This pathway, which has not been previously described for a cell surface receptor, may be different from the route followed by TfR in iron uptake, since reported rates of transferrin uptake and release are significantly more rapid than the resialylation of asialo-TfR.
In recent years, it has become clear that plasma membrane proteins move into and out of cells. Membrane proteins are exchanged between the cell surface and intracellular organelles during the uptake of membrane by pinocytosis and phagocytosis and during the addition of membrane by the fusion of intracellular vesicles with the plasma membrane (for reviews, see references 7, 17, and 49). These processes have been studied extensively by microscopic and cell fractionation techniques. The movement of surface proteins into coated vesicles and endosomes during pinocytosis and into phagosomes and secondary lysosomes during phagocytosis have been described in studies that have used specific antibodies and ligands as probes. However, these noncovalently bound probes may not report accurately on the intracellular transport of surface proteins, since they may dissociate from their original binding sites after endocytosis. In addition, these techniques yield information about only the distribution of the probe at the moment the cells are examined.
To overcome some of these problems, we are studying intracellular protein transport using covalent modifications of cell surface proteins as probes. This approach was inspired by the many studies that have followed the movement of newly made proteins through organelles of the secretory apparatus by analyzing the posttranslational modifications that occur in those organdies (24, 48) . Our strategy involves making covalent alterations to cell surface components so that they become substrates for enzymes of known intracellular location. Movement of proteins to the enzyme-containing compartment can then be monitored by studying the covalent structure of the molecule.
In this paper, we describe the development of an assay of this type that uses the sialic acid residues of cell surface glycoproteins to monitor movement to the Golgi complex. Cells are treated with neuraminidase to remove sialic acid residues from surface glycoproteins. The movement of these asialoglycoproteins to the Golgi complex, the major intracellular site of sialyltransferases, is then followed by monitoring the addition of sialic acid.
We have followed the intracellular movement of the transferrin receptor (TIR) ~ using this assay. It is one of many fuged from suspension, and the pellets were lysed in ice cold 1% Nonidet P-40 (NP-40) in PNE (10 T cells/ml). After 20 min on ice, lysates were centrifuged 2 rain at 13,000 g, supernatants decanted, and 1/10 vol of 10% NP-40, 10% sodium deoxycholate, 1% SDS in PNE was added. TfR was immunoprecipitated from lysates by use ofB3/25 anti-human transferrin receptor monoclonal antibody (Boehringer Mannheim Biochemicals, Indianapolis, IN), goat antimouse IgG, and fixed Staphylococcus aureus cells (both the gift of Dr. Douglas Fambrough, Carnegie Institution of Washington) according to Omary and Trowbridge (39) except that the entire procedure was carried out in PNE buffer to inhibit any remaining neuraminidase (1) .
When lysates were treated with neuraminidase, cells were lysed in 1% NP-40 in PBS and centrifuged as described above. The supernatants were then incubated for 30 min at 37"C with 60 mU neuraminidase/ml. Samples were then chilled, brought to 3 mM EDTA, and 1/10 vol of 10% NP-40, 10% sodium deoxycholate, 1% SDS in PNE was added. TfR was then immunoprecipitated as described above.
Binding of TfR to Transferrin-Sepharose: Human transferrin saturated with iron was coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N J) as described in the manufacturer's technical literature, yielding an absorbent with 5 mg transferrin/ml of gel. Labeled cells were lysed in 1% NP-40 in PNE (l ml/107 cells), and the lysate was cleared by centrifugation at 13,000 g for 2 rain. Supernatant (100 #l) was then incubated for 30 min at room temperature with 25 #l transferrin-Sepharose in 0.5 ml of 0.1 M sodium citrate (pH 5.5), 0.5 M NaCl, 0.2% Triton X-100, and l mM phenylmethanesulfonyl fluoride (5) . Tubes were then centrifuged, washed twice in the above buffer, and twice with 0.5 ml of l0 mM sodium citrate (pH 5.5), 0.5% NP-40, 0.5% sodium taurocholate, and 0.05% SDS. Specificity of binding was ensured by examination of binding to underivatized Sepharose 4B and to transferrin-scpharose in the presence of 1 mg/ml iron-saturated human transferrin.
Uectrophoresis and Isoelectric focusing: Samples prepared
from 5 x l0 s 12Sl-labeled cells or 1.25 x 10 + 35S-labeled cells were analyzed. Immune complexes and material bound to transferrin-Sepharose were dissociated in sample buffer and analyzed on 7.5% polyacrylamide gels in the presence of SDS according to Laemmli (33) . Isoelectric focusing on horizontal polyacrylamide gels containing urea was carried out essentially as described by O'Farrell (38) , except that polybuffer 74 diluted 1:10 and Polybuffer 96 diluted 1:8 (Pharmacia Fine Chemicals) were used as ampholytes (41) . Immune complexes were dissociated in 9.5 M urea, 2% dithiothreitol, 2% NP-40 (Particle Data Inc., Elmhurst, IL), 0.5% SDS, and Polybuffers 96 and 74, each diluted 1:9 for 30 min at 37"C. The samples were loaded on the gel by use of filter paper wicks placed close to the basic electrode. Focusing was peformed at 800 V for 16 h followed by 1,500 V for 0.5 h. Gels were fixed in 10% trichloroacetic acid (wt/vol) and then soaked in 25% isopropanol, 10% acetic acid, and dried. Autoradiography of ~zSI-labeled samples was carried out on Kodak XAR film by use of Dupont Cronex Lightning Plus intensifying screens, aSS-labeled samples were visualized by fluorography in gels that were soaked in Enlightning (New England Nuclear, Boston, MA) before they were dried.
Quantitation of Asialo-TfR Resialylation:
Individualbandswere located on dried gels by alignment with autoradiograms; they were then cut out, and counted in a Packard gamma counter. The percentage of the total radioactivity in the acidic species 6-10 (A) (see Results), was calculated to correct for the degradation of labeled TfR during culture of labeled cells. This way of grouping the data was chosen because these are the major TtR species both in control iodinated cells and in cells metabolically labeled with [35S]Met, whereas species 1-5 are found only in neuraminidase-treated cells.
The resialylation of asialo-TfR was calculated from these values according to the equation: percent sialylation = (Amr*t~e-Ao/Aco~tro~-Ao) X 100, where A,~t~ and Ao are the percentage of total TfR found in the acidic species in control and neuraminidase-treated cells, respectively, that had not been recultured. The sialylation value ranges from 0% in neuraminidase-treated cells before reculture to 100% in control cells.
RESULTS

Characterization of Cell Surface 12SI-TfR
Surface TfR was analyzed by isoelectric focusing of 1251-TfR immunoprecipitated from surface-labeled cells (Fig. 1) . Labeled receptor consisted of five major species with pI 5.2-6.0 (bands 6-10). The sialic acid content of these forms was determined by incubation of intact cells with increasing amounts of V. cholerae neuraminidase (Fig. 1 differ in composition by one sialic acid residue. Since species 7-9 are the major species in control cells, whereas species 3-5 are the principal species in treated cells, neuraminidase treatment removed 2-4 sialic acid residues from surface TfR. This is consistent with the reported existence of 1-2 complex asparagine-linked oligosaccharides on TfR (46) . The nature of the heterogeneity of asialo-TtR is not understood but may be due to the presence of phosphate residues, which have been found in TfR from other human cell lines (39, 46) .
In all subsequent experiments, 6 mU of neuraminidase was used to treat 106 cells. These conditions removed nearly all the accessible sialic acid residues from surface TfR since treatment with twice as much enzyme did not alter the pattern. Because all of the ~2SI-TIR was accessible to neuraminidase in intact cells at 0*C, all of these molecules were on the cell surface. This experiment also shows that the removal of sialic acids from TfR does not affect its immunoprecipitation, since equal amounts of t25I-TIR were recovered from all the samples.
K562 Cells Resialylate Asialo-TfR
The fate of surface asialo-TfR was studied in labeled cells that were treated with neuraminidase at 0*C and then incubated in growth medium at 37"C. Acidic TfR species began to reappear within 30 min, with a corresponding decrease in the basic species (Fig. 2) . Most notable are the increases in the acidic forms 7 and 8 and the decreases in the species 3 and 4. After 20 h, TfR from neuraminidase-treated cells resembled receptor from control cells. The relative amounts of TfR species did not change when control cells were recultured for a similar period.
To prove that the acidic TfR species in recultured neuraminidase-treated cells had been resialylated, we treated lysates 828 THE JOURNAL OF CELL BIOLOGY -VOLUME 100, 1985 from recultured cells with neuraminidase. Labeled neuraminidase-treated and control cells were recultured and lysates prepared. The lysates were then incubated with or without neuraminidase, and the TfR species were analyzed (Fig. 3) . The acidic species that appeared during reculture of neuraminidase-treated cells were destroyed by this second treatment, with a corresponding increase in basic species. Thus the reappearance of acidic species is due to the addition of sialic acid residues to asialo-TfR. Moreover, because treated lysates from recultured control and neuraminidase-treated cells contained the same TfR species, no other modifications are made to asialo-TfR in recultured cells.
The resialylation of asialo-TfR in neuraminidase-treated cells was quantified by our measuring the radioactivity in bands cut from the gel shown in Fig. 2 . The extent of sialylation, which ranges from 0% in neuraminidase-treated cells that have not been cultured to 100% in control cells, was calculated as described in Materials and Methods (Fig. 4 a) . In recultured neuraminidase-treated cells, resialylation had a half-time of 2-3 h. Moreover, the recovery was nearly complete, since sialylation reached 85% by 20 h. The sialylation value in control cells remained close to 100% during the same time in culture.
The degradation rates of labeled TfR and asialo-TfR were also quantified in this experiment. A semi-log plot of the total radioactivity in TfR (Fig. 4 b) showed that labeled TfR was lost from control and neuraminidase-treated cells with identical kinetics. A small fraction of the J25I-TfR was rapidly degraded, while the remainder disappeared with first order kinetics. The half-lives of the slow phase of turnover were 15.3 and 14.7 h in control and treated cells, respectively. This finding, combined with the fact that the amounts of the labeled acidic TfR species increased during the reculture of neuraminidase-treated cells ( 
SNIDER AND ROGERS Resialylation of Asialo-Transferrin Receptor Internalization of Asialo-TfR and Transport to a Post-endosomal Compartment Are Required for Resialylation
We performed experiments to test whether asialo-TfR is resialylated on the cell surface or in an intracellular organdie. First, we examined the temperature dependence of the process. Temperatures below 20"C block many intraceUular transport processes. These include the transfer of receptor-bound ligands from endocytic vesicles to lysosomes (11, 34, 45) , phagocytosis by macrophages (42) , and the movement of newly made glycoproteins from the Golgi to the cell surface (35) . Table I shows that resialylation was observed at 37, 31, and, to a lesser extent, 25*(2, but not at 18 or 10*C. No change in receptor composition was seen in control cells at any temperature. This result suggests that asialo-TfR must be transported to an intracellular compartment to be resialylated.
To exclude the possibility that inhibition of sialyltransferase activity caused the reduction of resialylation at low temperature, we examined the sialylation of newly made TfR at low temperature. Cells were pulse-labeled with [35S]Met at 37"C, chased briefly at 37"C, and the chase was continued at various temperatures and TfR analyzed by isoelectric focusing (Fig.  5) . During chase at 18, 25, 31, and 37"C, TfR was shifted from species 1-5 to species 6-10, indicating that sialylation was occurring, although smaller amounts of the acidic species were made at the lower temperatures. Of greatest significance is the fact that newly made TfR is sialylated at 18"C, indicating that sialyltransferases are active at this temperature. Thus, the absence of surface asialo-TfR resialylation at 18"C is due to the inhibition of transport to the intracellular organelle where the reaction occurs.
As a further test of the location of asialo-TfR resialylation, we examined the effects of chemical inhibitors of endocytosis. Monensin, a monovalent cation ionophore that interferes with both endocytosis and exocytosis (2, 52, 53) was used (Table II) . This compound completely blocked resialylation at 25 #M, whereas 70% inhibition was seen with 10 #M monensin. In addition, ammonium chloride, a compound that blocks transport of cell surface ligands from endocytic vesicles to lysosomes (18, 20, (54) (55) (56) , was studied. This compound caused 25 and 55% inhibition at 10 and 20 mM, respectively. None of these treatments had any effect on t25I-TfR in control cells.
The blockade of resialylation by reduced temperature, monensin, and ammonium chloride all support the idea that cell surface asialo-TfR must be transported to an intracellular organelle to be resialylated. Specifically, these treatments allow uptake of cell surface molecules into endosomes (7, 49, 57) , smooth-surfaced vesicles found in the peripheral cytoplasm, but block transfer out of this compartment. Thus, resialylation does not occur at the cell surface or in endosomes, but must take place in another organeUe.
Location of Resialylated YfR
Cell surface asialo-TfR is resialylated after transport to an intracellular compartment. To learn whether resialylated mol- Cells were iodinated, treated with neuraminidase, and recultured in growth medium with the indicated additions for 3.5 h at 37'C. Monensin was added as a 120-raM stock in ethanol. Transferrin receptor was then isolated and analyzed, as described in Materials and Methods.
ecules remain in this compartment or return to the cell surface, labeled neuraminidase-treated or control cells were cultured at 0 or 37"C for 3.5 h and then retreated with neuraminidase at 0*C (Fig. 6 ). Roughly half of the resialylated TfR (species 6-10) in neuraminidase-treated cells cultured at 37"C was digested by the second treatment. This suggests that this fraction of the resialylated molecules had returned to the cell surface. A similar fraction of the 125I-TfR was found on the cell surface when control cells were cultured at 37"C and then treated with neuraminidase. A second neuraminidase treatment of treated cells cultured at 0*C had no effect, because no resialylation had occurred. In control cells cultured at 0*C, neuraminidase treatment completely desialylated 125I-TfR, since all the 12SI-TfR had remained on the cell surface.
Effect of Transferrin on Resialylation of Asialo-TfR
Similar amounts of resialylation occurred when labeled neuraminidase-treated cells were cultured in serum-free medium or growth medium, indicating that transferrin is not required for this process (Table III) . Surprisingly, addition of human transferrin to serum-free medium caused a reduction in the extent of resialylation. Although human transferrin decreased resialylation, the bovine transferrin in the fetal calf serum present in the growth medium had no effect. This can be explained by the finding that bovine transferrin binds poorly to TfR on K562 cells (32) .
There are two possible explanations for the inhibition of asialo-TfR resialylation by human transferrin. First, the ligand could alter the intracellular transport of TfR, with the unoccupied receptor having a better chance of reaching the site where resialylation occurs. Alternatively, if TfR oligosaccharides are sterically hindered by bound transferrin, then TfRtransferrin complexes might not be resialylated, even though transport to the correct intracellular compartment had oc-FIGURE 6 Resialylated TfR appears on the cell surface. Iodinated neuraminidase-treated and control cells were cultured for 3.5 h at the indicated temperatures and then washed and incubated at O°C with or without neuraminidase. TfR was then immunoprecipitated and analyzed by isoelectric focusing as described in Materials and Methods. An autoradiograph of the dried gel is shown, with the acidic end at the top. Bands are numbered as in Fig. 1. curred. Though it is not possible to decide among these alternatives, the idea that transferrin reduces the accessibility of TfR oligosaccharides is supported by evidence that bound ligands interfere with the action of neuraminidase on TfR. Removal of sialic acid residues from TtR in cell lysates was inhibited by human transferrin (not shown). In addition, sialic acid residues were not removed when TfR-anti-TfR monoclonal antibody complexes were treated with neuraminidase (46) .
TfR Function Is Not Affected by Neuraminidase Treatment
The resialylation of asialo-TfR is a valid assay for the intracellular transport of receptor only if the absence of sialic acid does not affect the behavior of TfR. Several experiments have been performed to show that this is the case. First, as discussed above, the half-lives of cellular t25I-TtR and 1221-asialo-TfR are the same, indicating that removal of sialic acid residues does not affect receptor stability. In addition, TIP, and asialo-TfR bind transferrin equally well. Extracts from 125I-labeled cells were incubated with transferrin-Sepharose and the bound proteins eluted and analyzed on an SDS polyacrylamide gel (Fig. 7) . In samples from control and neuraminidase-treated cells, a single polypeptide was bound (lanes c and f ) which migrated with immunoprecipitated TfR and asialo-TfR (lanes a and h). The specificity of this binding was established by the fact that TfR and asialo-TfR did not bind to Sepharose (lanes b and e) or to transferrin-Sepharose in the presence of excess-free transferrin (lanes d and g) . Because equal amounts of TfR and asialo-TfR were recovered from transferrin-Sepharose, neuraminidase treatment did not affect the transferrin binding activity of TtR. Moreover, iodination did not greatly alter the transferrin-binding properties of TfR since the amount of immunoprecipitated receptor was the same as the amount bound to transferrin-Sepharose.
The rapid internalization of cell surface asialo-TfR was also demonstrated as a further check on receptor function. Neuraminidase-treated and control cells were incubated with transferrin at 0*C to saturate surface binding sites. One set of samples was kept at 0*C, whereas a second set was warmed to 37"C briefly to allow internalization of receptor-ligand complexes. Surface TfR was then labeled by iodination at 0*C (Fig. 8) . While only asialo-TfR was found on the surface of Cells were iodinated, treated with neuraminidase, and recuitured in the indicated media for 3.5 h at 37°C. BSA (1 mg/ml) and iron-saturated human lransferrin (0.3 mg/ml) were added where indicated. Transferrin receptor was then isolated and analyzed, as described in Materials and Methods. neuraminidase-treated ceils kept at 0°C, 60% of the labeled TfR in warmed cells was sialylated. Thus, during the brief incubation at 37°C, much of the surface asialo-TfR was internalized and replaced by TfR from internal pools that had not been exposed to neuraminidase. This rate of internalization of asialo-TfR is comparable to that measured for TfR, both directly (5), and by monitoring the internalization of transferrin (8, 28, 30, 32, 37) . In control cells that were not exposed to neuraminidase, the 37°C incubation did not affect the composition or amount of surface TfR; the expected internalization of TfR and its replacement by identical molecules cannot be detected by this experiment.
Finally, we examined the effect of neuraminidase and iodination on cell growth and viability. When neuraminidasetreated and control cells were cultured for 20 h, the two cultures contained the same number of cells and >98% of the cells in both samples excluded trypan blue. The rates of DNA and protein synthesis, measured by the incorporation of [3H]thymidine and [3SS]Met into acid-precipitable material, were also the same in neuraminidase-treated and control cultures (not shown). In addition, after iodination, >95% of the cells excluded trypan blue. 
D I S C U S S I O N
We have taken advantage of a new approach to examine the intracellular movement of cell surface proteins. The method involves alteration of surface molecules to make them substrates for enzymes of known intracellular location. Transport to the intracellular compartment that contains the enzymes is then monitored by analysis of isolated proteins. This strategy has several advantages over previously used techniques. First, our approach offers a significant increase in sensitivity, since it provides an estimate of all the molecules that have passed through a compartment, rather than the number in that compartment when the cells are examined. For this reason, assays of this type should be able to detect the movement of cell surface molecules through organelles that contain a small fraction of the total pool at any moment. A second advantage is the use of covalent modifications to surface proteins as a probe, allowing molecules to be followed directly. In contrast, many other studies have used antibody and ligand probes, which may dissociate from their binding sites during the experiment. Nonspecific tracers, whose relation to individual membrane proteins is unclear, have also been used. A further advantage of covalent modifications as probes is that the modified surface molecules are stably altered when they reach the compartment under study, so that they can be followed after leaving the intracellular site of modification.
Our assay uses sialyltransferases to study the transport of cell surface glycoproteins to the Golgi complex. It is well established that these enzymes are found in the Golgi, most likely in the trans region of the organelle. Sialic acid is incorporated into glycoproteins and glycolipids in the Golgi complex in vivo in a number of tissues, as demonstrated by electron microscope autoradiography (3, 4) . Moreover, in cell fractionation experiments, the specific activity of sialyltransferase is highest in Golgi-derived membranes, and these membranes have most of the enzyme activity in the cell (16, 36) . The placement of sialyltransferases in the trans Golgi compartment is based on indirect evidence. Because galactosyltransferase and sialyltransferases are found in the same membranes during cell fractionation (6, 10, 12) and because morphological studies have localized galactosyltransferase to the trans Golgi (44), it is likely that sialyltransferase is also found in this part of the Golgi complex.
We have found that asialo-TfR generated on the cell surface is resialylated. Because sialyltransferases are located in the Golgi and because resialylation is blocked by treatments that interfere with the movement of molecules out of the endosomal compartment, it is likely that TfR is transported from the cell surface to the trans region of the Golgi complex. Moreover, since nearly all asialo-TfR molecules are resialylated, it is likely that they all pass through this compartment.
Though asialo-TiR molecules are resialylated in neuraminidase-treated cells, they do not become as highly sialylated as receptor in control cells. This could mean that surface asialoTfR and newly made TfR are not sialylated in the same compartment. However, a more likely explanation is that surface asialo-TfR is not identical in structure to newly made molecules, with the latter being better substrates for sialyltransferases. If asialo-TfR is a poor substrate for resialylation, then each molecule may make several trips through the Golgi complex before it is resialylated. Thus, transport through this compartment could be more rapid than the 2-3 h half-time of resialylation. This idea is supported by the possibility that bound transferrin interferes with asialo-TfR resialylation. Moreover, we have recently found that newly made TfR molecules on the cell surface have fewer sialic acid residues than older receptor molecules, with sialic acid residues being added to the TfR molecules over many hours (unpublished observations). This suggests that newly made TfR molecules pass through the Golgi without being fully sialylated and then mature as they return from the cell surface to the Golgi complex.
TfR does not accumulate at the site of resialylation, since roughly half of the resialylated TfR was found on the cell surface. Moreover, a similar fraction of receptor was found on the cell surface in studies with ~25I-TfR in recultured K562 cells, with [35S]Met-labeled TfR in K562 cells (unpublished observations), and with TfR in HeLa cells (5) . This suggests that resialylated TfR mixes rapidly with surface and internal receptor pools. It is not known whether resialylated TfR molecules return to the surface from the Golgi complex along the route used by newly made proteins, or whether some other pathway is used.
Several previous studies are consistent with the transport of TfR from the cell surface to the juxtanuclear region that contains the Golgi complex. In electron microscopic studies, anti-TfR bound to surface receptor was transported to this juxtanuclear region in cultured cells (26, 60) . In addition, Hopkins (25) and Yamashiro et al. (61) have found that transferrin bound to surface TfR moves into vesicles in the Golgi region. Moreover, when cells are incubated with transfen-in for long periods, material is accumulated in intracellular compartments that exchange slowly with the cell surface (37) . However, none of these studies have directly demonstrated the movement of transferrin-TfR complexes into Golgi cisternae.
Previous reports also support the existence of a transport pathway that carries other cell surface molecules through the Golgi complex. Electron microscopic studies have found that nonspecific tracers can be transported from the plasma membrane to the Golgi complex in many cell types (13, (21) (22) (23) 40) . Of particular interest is the fact that the tracers are usually found in greatest concentration in the rims of trans Golgi cisternae, which may be the sialyltransferase-containing elements. Willingham and Pastan (59) have also reported the transport of epidermal growth factor-horseradish peroxidase conjugates to the Golgi region. Moreover, Regoeczi et al. (43) found that asialotransferrin injected into rats was taken up by the liver and resialylated, presumably in the Golgi complex. This transport to the Golgi complex was probably mediated by the hepatic asialoglycoprotein receptor. Finally, surface 5'-nucleotidase in rat embryo fibroblasts was found to exchange with an internal pool with a half-time of 6 h, and electron microscopic evidence suggested that the internal pool is found in the Golgi region (58) .
What is the role of TfR transport to the Golgi complex in iron uptake? The rate transferrin uptake and release both in K562 cells and other cultured cells is very rapid; ligand bound to surface receptors is internalized, returns to the cell surface, and is released into the medium within 10-20 min (8, 30, 32, 37) . Our finding that surface asialo-TfR is resialylated with a half-time of 2-3 h suggests that not every transferrin-TfR complex moves through the Golgi complex during iron uptake. Alternatively, it is possible that only unoccupied receptors move through the Golgi complex. This could explain the inhibition of TfR resialylation by transferrin. The conclusion that transport of ligand-receptor complexes through the Golgi is not an obligatory part of ligand uptake was also reached for the intracellular transport of the hepatic asialoglycoprotein receptor based on electron microscopic observations (14) , although a substantial fraction of the internal pool of this receptor has recently been found in the Golgi complex (15) . However, microscopic studies on the uptake of epidermal growth factor suggest that transport to the Golgi complex may precede the movement of the hormone to lysosomes (59) .
The extent to which other surface proteins follow the transport pathway we have found for TfR is unknown. Transport to the Golgi complex could be unique to TfR, could be a property common to receptors involved in endocytosis, or could occur for all plasma membrane proteins. The internalization of 5'-nucleotidase and its return to the cell surface (58) suggest that proteins other than surface receptors move between the Golgi complex and the cell surface. However, a recent study on the major histocompatibility antigen suggested that this molecule does not follow the same pathway as TfR, since the oligosaccharide structures of this surface glycoprotein were stable throughout the life of the molecule (5 I). To understand the importance of surface protein movement through the Golgi complex, we are currently using the resialylation assay to examine the intracellular movement of other surface glycoproteins, including ones involved in endocytosis and others that are not; we are also studying the transport of TfR in relation to cellular iron metabolism.
